EMBL Conference: Stem Cells in Cancer and Regenerative Medicine
29 August 2012 - 01 September 2012
This conference will describe the role of stem cells in normal and diseased physiology, as well as the ways in which stem cells can be used for curative ends. The overall aim is to integrate basic, translational and clinical aspects of stem cell research into a single framework.
EMBL Advanced Training Centre, Heidelberg, Germany
http://www.embl.de/training/events/2012/STM12-01/
22nd International Symposium on Medicinal Chemistry
02 September 2012 - 06 September 2012
This symposium is recognized worldwide as one of the leading Medicinal Chemistry meetings, as proven by its large international attendance, which varies between 1200 and 1500 participants from all over the world. It traditionally attracts experts in drug discovery and development, in particular medicinal and synthetic chemists, together with scientists active in the fields of computer assisted drug design, biology, DMPK, pharmacology, early toxicology, as well as chemical and pharmaceutical development.
The EFMC-ISMC 2012 will continue its tradition and will cover drug discovery advances in all major therapeutic areas as well as the most recent advances in lead identification and optimization strategies, drug design and profiling technologies. Particular emphasis will be put on first time disclosures. ISMC 2012 will also illustrate the impact of the -omics and biomarker areas on the interfaces between chemistry, informatics, biology and experimental medicine.
Berlin, Germany
http://www.ldorganisation.com/produits.php?langue=english&cle_menus=1238915417
Drug Delivery Technologies & Formulation
05 September 2012 - 06 September 2012
This exciting event will provide education, communication and networking opportunities for both the scientific and business leaders engaged in drug delivery and formulation. We will bring together leaders from academia, biotech and industry to discuss the current challenges and new strategies to succeed in this evolving area.
tbc Zurich, Switzerland
http://www.gtcbio.com/component/conference/?file=home&cn=Drug+Delivery+Technologies+&Formulation=&cid=94
Drug Discovery 2012
05 September 2012 - 06 September 2012
As in previous years the objective of this conference is to provide a communication, education and networking opportunity for scientists engaged in early-phase drug discovery whether in academia, biotech or industry. As with our highly successful meeting in 2011, attendees will hear world class speakers discussing the challenges and opportunities facing the drug discovery scientist. The scientific sessions will be complemented by a large poster session, a growing vendor exhibition with over 100 exhibitors including the Innovation Zone, a Media Area, Careers Zone and a number of training sessions. This year we are featuring a Lunchtime Session sponsored by SLAS – Informatics: Making Knowledge from Laboratory Data
Manchester Central Convention Complex, UK
http://www.elrig.org/index.php/events/drug-discovery-2012
Proteins & Biopharma World Asia Congress
10 September 2012 - 11 September 2012
Over two days, this event will attract over 175 senior-level decision makers working in upstream and downstream production from Asia Pacific. This prestigious event provides a forum for practitioners and prominent innovators to learn more about key solutions being provided to their industry, network with their peers, and address key industry concerns through a series of cutting edge conference presentations in a professional yet relaxed environment.
tbc Singapore
http://www.biopharmasia-congress.com/
13th International Alzheimer’s Disease Drug Discovery Conference
10 September 2012 - 11 September 2012
This annual Alzheimer's Drug Discovery Foundation (ADDF) conference brings together academic and industry scientists intent on accelerating the development of innovative treatments for Alzheimer’s disease and related dementias.
The ADDF’s funded investigators and top level scientists in the field will present on their current research progress and stimulate discussion. The conference offers ample opportunities for collaboration and partnering
Hyatt Regency Jersey City, NJ, USA
http://www.worldeventsforum.com/addf/addrugdiscovery/
Modeling & Design of Molecular Materials 2012
10 September 2012 - 14 September 2012
MDMM is a biannual conference devoted to presenting contemporary computational methods along
with their applications in molecular modeling and molecular material design and related fields.
Participation of experimentalists interested in application molecular modeling techniques is
encouraged.
Wroclaw, Poland
http://mdmm.pl/2012/
4th Annual Personalized Medicine Conference
12 September 2012 - 13 September 2012
Arrowhead's 4th Annual Personalized Medicine Conference will tackle the issues driving as well as restraining the clinical delivery of personalized medicine, including coding and reimbursement, the economics of personalized medicine and medicare policy.
tbc. Boston, MA, USA
http://www.personalizedmedicinepartnerships.com/venue
PharmSci 2012 The Science of Medicines
12 September 2012 - 14 September 2012
The PharmSci 2012 Conference will showcase the best of pharmaceutical science from the UK and around the world bringing together academic and industrial institutions, providing state of the art technologies and a platform for the development of new pharmaceutical talent. The intention is to work with related partner organisations such as, JPAG, UK&ICRS, and the RPS together with the Academy's focus groups to deliver a high quality science programme.
East Midlands Conference Centre, UK
http://www.ukpharmsci.org/Default.asp
EMBO | EMBL Symposium: Diabetes and Obesity
13 September 2012 - 16 September 2012
This EMBO | EMBL Symposium aims to bring together established experts, physician scientists and basic researchers to discuss the multi-layered and complex processes leading up to novel therapeutic strategies for diabetes, obesity and related health issues, such as cancer and cardiovascular disease, including:
Mechanistic translational research addressing controversies of clinical relevance for diabetes and obesity
Systems biology approaches dissecting multi-organ communication in the pathophysiology of metabolic disease
Unraveling the emerging molecular interplays between immune processes and metabolic pathways
Exploring novel insight into mechanisms of bariatric surgery and combination therapies for the development of future pharmacologics
EMBL Advanced Training Centre, Heidelberg, Germany
http://www.embo-embl-symposia.org/symposia/2012/EES12-05/
2nd CNS Diseases World Summit
13 September 2012 - 14 September 2012
2nd CNS Diseases World Summit brings together experts from academia and industry to discuss cutting edge research and new technologies used in the pharmaceutical and biotech fields. The summit takes place in San Francisco, CA on September 13-14, 2012 and includes three concurrent tracks.
2nd Neuropsychiatric Research and Development
6th Neurodegenerative Conditions Research and Development
5th CNS Partnering and Deal-making
Pain Research and Therapeutics
Hilton San Francisco Financial District, San Francisco, CA, USA
http://www.gtcbio.com/component/conference/?file=home&cn=2nd+CNS+Diseases+World+Summit&cid=39
Pain Research and Therapeutics
13 September 2012 - 14 September 2012
The Pain Research and Therapeutics conference brings together the leading experts across industry and academia to discuss their findings on Pain and cutting edge applications for drug delivery, therapeutic approaches, preclinical and clinical development, animal models, beyond traditional opiods, and much more. The conference will focus on the following sessions:
Plenary Keynote Session
Session: Policy Change and Therapeutic Change
Session: New Biology and Animal Models
Session: Novel Therapeutic Targets and Developments
Session: Beyond Traditional Opioids
Session: Preclinical and Clinical Development
Session: Overcoming Challenges in Pain Therapeutics
Hilton San Francisco Financial District, San Francisco, CA, USA
http://www.gtcbio.com/index.php?option=com_conference&file=home&cn=Pain%20Research%20and%20Therapeutics&cid=90
Next-Generation Sequencing
17 September 2012 - 18 September 2012
SMi’s Next-Generation Sequencing conference focuses exclusively on the data interpretation and analytical challenges facing genomics and computational biology today. Whether working with microbial or human DNA, the latest developments to extract biological meaning from short-reads, oligonulceotide sequences or whole genome studies are showcased in this innovative meeting. Themed sessions and workshops utilise real-life case studies to enhance your problem-solving, interpretation and analytical skills.
Copthorne Tara Hotel, London
http://www.smi-online.co.uk/goto/next-generationsequencing43.asp
10th Annual Pharmaceutical IT Congress
17 September 2012 - 18 September 2012
The 9th Annual Pharma IT meeting will attract over 150 senior-level decision makers working in R&D IT and pharmaceutical technology from leading pharmaceutical, biotech companies, academic and research institutions. This prestigious event covers topic areas such as effective tools and solutions in data management, knowledge management, informatics and data sharing for collaborative research in preclinical and clinical drug development, as well as successful strategies in managing IT Infrastructure and architecture using tools such as cloud computing, semantic web for data, content management and collaborative networking in life science.
Radisson Edwardian Hotel, London Heathrow, London, UK
http://www.pharmatechnology-summit.com/
4th RSC-SCI symposium on GPCRs in Medicinal Chemistry
17 September 2012 - 19 September 2012
G-protein-coupled receptors (GPCRs) play a crucial role in transmitting chemical signals across cell membranes and converting them into cellular responses. As such, they are involved in many diseases and continue to represent the target of a large proportion of all modern medicinal drugs. Building on the success of the previous three meetings, the next meeting in this series will be supported by Lilly UK.
Lilly Research Centre Ltd., Erl Wood Manor, Windlesham, GU20 6PH, Surrey, UK
http://www.maggichurchouseevents.co.uk/bmcs
Biosimilars and Biobetters
19 September 2012 - 20 September 2012
Following the success of our past events, SMi’s third Biosimilars and Biobetters conference will build upon the progress made in previous meetings and further develop the ideas and strategies that were debated and discussed. In particular how industry players will face regulatory challenges in approval of follow on biologics, rising development costs, threat from competition and a similar if not bigger challenge to that seen in marketing of innovator drugs.
There will be case studies from those who are both developing and distributing follow on biologics. With analysis of key trends in biologic pipelines, methods in clinical trials for biosimilar approval, a review of emerging markets, assessment of biosimilar manufacturing, post approval strategy and future forecasting for follow on biologics.
SMi’s Biosimilars and Biobetters event will provide up to date information from key opinion leaders in the biologics industry with discussion and debate and opportunities for networking between CROs, CMOs, law firms, regulatory bodies, pharma and biotechs.
Copthorne Tara Hotel, London, UK
http://www.smi-online.co.uk/events/overview.asp?is=4&ref=4011&utm_source=P-043&utm_medium=EM%20-%201S&utm_campaign=GroupMail
Cancer Vaccines
19 September 2012 - 20 September 2012
SMi is proud to present their inaugural conference on Cancer Vaccines. This new and exciting event will bring together senior Pharma representatives and key academics to discuss current developments of cancer immunotherapeutics, engineering vaccine adjuvant formulations, advances and challenges in the advancement of novel therapeutic cancer vaccines and much more.
With presentations from industry representatives from the top 50 pharmaceutical companies, this event promises to be a unique platform for networking, and learning from case studies and problem solving.
Copthorne Tara Hotel, London
http://www.smi-online.co.uk/cancervaccinesevent4.asp
Fragment-based Lead Discovery Conference 2012
23 September 2012 - 26 September 2012
Fragment-based methods are demonstrating success in both drug discovery and in identifying tools for chemical biology. The 2012 meeting is structured to reflect the discovery pipeline; presentations from different specialties will be grouped together to highlight the interplay between different scientific areas to drive the fragment-to-optimised compound process.
San Francisco, USA
http://www.ysbl.york.ac.uk/fbld/2012/FBLD2012drafttimetable.html
Biomarkers 2012
26 September 2012
Biomarker professionals will gather together to answer the all-important question- how can we get biomarkers to add value? How do you develop new medicines, which demonstrate real value through predictable outcomes in targeted patient groups? The event is a one day strategic conference tackling these questions and providing participants with a thorough review of the use of biomarkers, their effectiveness and their potential to transform R & D.
London Marriott Marble Arch Hotel, London, UK
http://www.virtueinsight.com/pharma/Biomarkers-2012/